Eli Lilly headquarters in Indianapolis. Pharmaceutical giant Eli Lilly (LLY) is putting $4.5 billion toward building a new site to develop and manufacture drugs. The Lilly Medicine Foundry ...

Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased a 323,930-square-foot industrial building in the ...

Lilly (NYSE: LLY) makes drugs including Mounjaro for type 2 diabetes and Zepbound for obesity. For 2023, it reported $34 ...

Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased 30.9 acres of vacant land to the north and to the ...

On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks ...

The company reported revenue of $11.4 billion and adjusted earnings of $1.18 per share, well below the consensus estimates of $12.1 billion and $1.45, respectively.

Eli Lilly wants the public to know it’s more than just a manufacturer ... However, during that time, Lilly has embarked on a greater corporate brand-building effort that it hopes will elevate its ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

Yet, Eli Lilly's GLP-1 medications are helping it compete ... it seems the company is content taking its time building a presence in the market, and is not in a rush to oversell its products.

ODBM is one of 91 organizations that received grants through a competitive round of Lilly Endowment’s Nurturing Children ...

Eli Lilly to invest £279 million in a new UK Gateway ... The global pharmaceutical giant is set to invest in a new Gateway Lab in the U.K., building on the country's leading life sciences sector.